{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:40:51Z","timestamp":1791038451889,"version":"4.1.0"},"reference-count":112,"publisher":"Baishideng Publishing Group Inc.","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.2190","type":"journal-article","created":{"date-parts":[[2009,5,14]],"date-time":"2009-05-14T06:09:16Z","timestamp":1242281356000},"page":"2190","source":"Crossref","is-referenced-by-count":67,"title":["Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms"],"prefix":"10.3748","volume":"15","author":[{"given":"Giada","family":"Sebastiani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, McHugh JA, Petersen GM, Rein MF. National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. Ann Intern Med 2009;150:104-110.","DOI":"10.7326\/0003-4819-150-2-200901200-00100"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003;362:2089-2094.","DOI":"10.1016\/S0140-6736(03)15108-2"},{"key":"ref3","unstructured":"Global surveillance and control of hepatitis C. Report of a who consultation organized in collaboration with the viral hepatitis prevention board, antwerp, belgium. J Viral Hepat 1999;6:35-47."},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Alberti A, Chemello L, Benvegnu L. Natural history of hepatitis C. J Hepatol 1999;31 Suppl 1:17-24.","DOI":"10.1016\/S0168-8278(99)80369-9"},{"key":"ref5","unstructured":"de Franchis R, Hadengue A, Lau G, Lavanchy D, Lok A, McIntyre N, Mele A, Paumgartner G, Pietrangelo A, Rodes J. EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 2003;39 Suppl 1:S3-S25."},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Bonkovsky HL, Lambrecht RW, Shan Y. Iron as a co-morbid factor in nonhemochromatotic liver disease. Alcohol 2003;30:137-144.","DOI":"10.1016\/S0741-8329(03)00127-7"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Day CP, Bassendine MF. Genetic predisposition to alcoholic liver disease. Gut 1992;33:1444-1447.","DOI":"10.1136\/gut.33.11.1444"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003;289:3000-3004.","DOI":"10.1001\/jama.289.22.3000"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.","DOI":"10.1016\/S0016-5085(99)70506-8"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology 1999;29:664-669.","DOI":"10.1002\/hep.510290347"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Bugianesi E, Manzini P, D’Antico S, Vanni E, Longo F, Leone N, Massarenti P, Piga A, Marchesini G, Rizzetto M. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 2004;39:179-187.","DOI":"10.1002\/hep.20023"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Duvnjak M, Lerotic I, Barsic N, Tomasic V, Virovic Jukic L, Velagic V. Pathogenesis and management issues for non-alcoholic fatty liver disease. World J Gastroenterol 2007;13:4539-4550.","DOI":"10.3748\/wjg.v13.i34.4539"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Day CP, James OF. Steatohepatitis: a tale of two “hits”? Gastroenterology 1998;114:842-845.","DOI":"10.1016\/S0016-5085(98)70599-2"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Friedman SL. Liver fibrosis -- from bench to bedside. J Hepatol 2003;38 Suppl 1:S38-S53.","DOI":"10.1016\/S0168-8278(02)00429-4"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Sebastiani G, Alberti A. Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy. World J Gastroenterol 2006;12:3682-3694.","DOI":"10.3748\/wjg.v12.i23.3682"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-435.","DOI":"10.1002\/hep.1840010511"},{"key":"ref17","unstructured":"Ishak KG. Chronic hepatitis: morphology and nomenclature. Mod Pathol 1994;7:690-713."},{"key":"ref18","unstructured":"Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994;20:15-20."},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-2474.","DOI":"10.1111\/j.1572-0241.1999.01377.x"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Maharaj B, Maharaj RJ, Leary WP, Cooppan RM, Naran AD, Pirie D, Pudifin DJ. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986;1:523-525.","DOI":"10.1016\/S0140-6736(86)90883-4"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Poniachik J, Bernstein DE, Reddy KR, Jeffers LJ, Coelho-Little ME, Civantos F, Schiff ER. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 1996;43:568-571.","DOI":"10.1016\/S0016-5107(96)70192-X"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Abdi W, Millan JC, Mezey E. Sampling variability on percutaneous liver biopsy. Arch Intern Med 1979;139:667-669.","DOI":"10.1001\/archinte.1979.03630430043014"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, Feng ZZ, Reddy KR, Schiff ER. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002;97:2614-2618.","DOI":"10.1111\/j.1572-0241.2002.06038.x"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003;39:239-244.","DOI":"10.1016\/S0168-8278(03)00191-0"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Colombo M, Del Ninno E, de Franchis R, De Fazio C, Festorazzi S, Ronchi G, Tommasini MA. Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. Gastroenterology 1988;95:487-489.","DOI":"10.1016\/0016-5085(88)90509-4"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Rousselet MC, Michalak S, Dupre F, Croue A, Bedossa P, Saint-Andre JP, Cales P. Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005;41:257-264.","DOI":"10.1002\/hep.20535"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Wong JB, Koff RS. Watchful waiting with periodic liver biopsy versus immediate empirical therapy for histologically mild chronic hepatitis C. A cost-effectiveness analysis. Ann Intern Med 2000;133:665-675.","DOI":"10.7326\/0003-4819-133-9-200011070-00008"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Hubscher SG. Histological grading and staging in chronic hepatitis: clinical applications and problems. J Hepatol 1998;29:1015-1022.","DOI":"10.1016\/S0168-8278(98)80134-7"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004;99:1160-1174.","DOI":"10.1111\/j.1572-0241.2004.30110.x"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Guido M, Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 2004;24:89-97.","DOI":"10.1055\/s-2004-823103"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-1457.","DOI":"10.1053\/jhep.2003.09022"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Scheuer PJ. Liver biopsy size matters in chronic hepatitis: bigger is better. Hepatology 2003;38:1356-1358.","DOI":"10.1053\/jhep.2003.10010"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 2000;32:477-481.","DOI":"10.1053\/jhep.2000.16602"},{"key":"ref34","unstructured":"Bonny C, Rayssiguier R, Ughetto S, Aublet-Cuvelier B, Baranger J, Blanchet G, Delteil J, Hautefeuille P, Lapalus F, Montanier P. [Medical practices and expectations of general practitioners in relation to hepatitis C virus infection in the Auvergne region]. Gastroenterol Clin Biol 2003;27:1021-1025."},{"key":"ref35","unstructured":"Almasio PL, Niero M, Angioli D, Ascione A, Gullini S, Minoli G, Oprandi NC, Pinzello GB, Verme G, Andriulli A. Experts’ opinions on the role of liver biopsy in HCV infection: a Delphi survey by the Italian Association of Hospital Gastroenterologists (A.I.G.O.). J Hepatol 2005;43:381-387."},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Castera L, Denis J, Babany G, Roudot-Thoraval F. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines? J Hepatol 2007;46:528-529; author reply 529-530.","DOI":"10.1016\/j.jhep.2006.12.002"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002 . Hepatology 2002;S3-S20.","DOI":"10.1053\/jhep.2002.37117"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Carosi G, Rizzetto M. Treatment of chronic hepatitis B: recommendations from an Italian workshop. Dig Liver Dis 2008;40:603-617.","DOI":"10.1016\/j.dld.2008.03.011"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, Hashimoto E, Lefkowitch JH, Ludwig J, Okuda K. The long-term pathological evolution of chronic hepatitis C. Hepatology 1996;23:1334-1340.","DOI":"10.1002\/hep.510230607"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"McHutchison JG, Blatt LM, de Medina M, Craig JR, Conrad A, Schiff ER, Tong MJ. Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group. J Gastroenterol Hepatol 2000;15:945-951.","DOI":"10.1046\/j.1440-1746.2000.02233.x"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Murawaki Y, Ikuta Y, Okamoto K, Koda M, Kawasaki H. Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C. J Gastroenterol 2001;36:399-406.","DOI":"10.1007\/s005350170084"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Halfon P, Bourliere M, Penaranda G, Deydier R, Renou C, Botta-Fridlund D, Tran A, Portal I, Allemand I, Rosenthal-Allieri A. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol 2005;4:6.","DOI":"10.1186\/1476-5926-4-6"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Pares A, Deulofeu R, Gimenez A, Caballeria L, Bruguera M, Caballeria J, Ballesta AM, Rodes J. Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis. Hepatology 1996;24:1399-1403.","DOI":"10.1002\/hep.510240615"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Suzuki A, Angulo P, Lymp J, Li D, Satomura S, Lindor K. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int 2005;25:779-786.","DOI":"10.1111\/j.1478-3231.2005.01064.x"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Guechot J, Laudat A, Loria A, Serfaty L, Poupon R, Giboudeau J. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis. Clin Chem 1996;42:558-563.","DOI":"10.1093\/clinchem\/42.4.558"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, Beuzen F, Capron F, Thabut D, Munteanu M. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol 2005;3:167-174.","DOI":"10.1016\/S1542-3565(04)00625-1"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Zhang YX, Wu WJ, Zhang YZ, Feng YL, Zhou XX, Pan Q. Noninvasive assessment of liver fibrosis with combined serum aminotransferase\/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World J Gastroenterol 2008;14:7117-7121.","DOI":"10.3748\/wjg.14.7117"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Rosa H, Parise ER. Is there a place for serum laminin determination in patients with liver disease and cancer? World J Gastroenterol 2008;14:3628-3632.","DOI":"10.3748\/wjg.14.3628"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aube C, Gallois Y, Rifflet H, Maiga MY, Penneau-Fontbonne D. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997;113:1609-1616.","DOI":"10.1053\/gast.1997.v113.pm9352863"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Santos VN, Leite-Mor MM, Kondo M, Martins JR, Nader H, Lanzoni VP, Parise ER. Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease. Braz J Med Biol Res 2005;38:747-753.","DOI":"10.1590\/S0100-879X2005000500012"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Walsh KM, Fletcher A, MacSween RN, Morris AJ. Basement membrane peptides as markers of liver disease in chronic hepatitis C. J Hepatol 2000;32:325-330.","DOI":"10.1016\/S0168-8278(00)80079-3"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Murawaki Y, Koda M, Okamoto K, Mimura K, Kawasaki H. Diagnostic value of serum type IV collagen test in comparison with platelet count for predicting the fibrotic stage in patients with chronic hepatitis C. J Gastroenterol Hepatol 2001;16:777-781.","DOI":"10.1046\/j.1440-1746.2001.02515.x"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Sakugawa H, Nakayoshi T, Kobashigawa K, Yamashiro T, Maeshiro T, Miyagi S, Shiroma J, Toyama A, Nakayoshi T, Kinjo F. Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease. World J Gastroenterol 2005;11:255-259.","DOI":"10.3748\/wjg.v11.i2.255"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Boeker KH, Haberkorn CI, Michels D, Flemming P, Manns MP, Lichtinghagen R. Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C. Clin Chim Acta 2002;316:71-81.","DOI":"10.1016\/S0009-8981(01)00730-6"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Cales P, Oberti F, Michalak S, Hubert-Fouchard I, Rousselet MC, Konate A, Gallois Y, Ternisien C, Chevailler A, Lunel F. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 2005;42:1373-1381.","DOI":"10.1002\/hep.20935"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Cales P, Laine F, Boursier J, Deugnier Y, Moal V, Oberti F, Hunault G, Rousselet MC, Hubert I, Laafi J. Comparison of blood tests for liver fibrosis specific or not to NAFLD. J Hepatol 2009;50:165-173.","DOI":"10.1016\/j.jhep.2008.07.035"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Patel K, Gordon SC, Jacobson I, Hezode C, Oh E, Smith KM, Pawlotsky JM, McHutchison JG. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004;41:935-942.","DOI":"10.1016\/j.jhep.2004.08.008"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Adams LA, Bulsara M, Rossi E, DeBoer B, Speers D, George J, Kench J, Farrell G, McCaughan GW, Jeffrey GP. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection. Clin Chem 2005;51:1867-1873.","DOI":"10.1373\/clinchem.2005.048389"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Naveau S, Gaude G, Asnacios A, Agostini H, Abella A, Barri-Ova N, Dauvois B, Prevot S, Ngo Y, Munteanu M. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease. Hepatology 2009;49:97-105.","DOI":"10.1002\/hep.22576"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Rosenberg WM, Voelker M, Thiel R, Becka M, Burt A, Schuppan D, Hubscher S, Roskams T, Pinzani M, Arthur MJ. Serum markers detect the presence of liver fibrosis: a cohort study. Gastroenterology 2004;127:1704-1713.","DOI":"10.1053\/j.gastro.2004.08.052"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Guha IN, Parkes J, Roderick P, Chattopadhyay D, Cross R, Harris S, Kaye P, Burt AD, Ryder SD, Aithal GP. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology 2008;47:455-460.","DOI":"10.1002\/hep.21984"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Nobili V, Parkes J, Bottazzo G, Marcellini M, Cross R, Newman D, Vizzutti F, Pinzani M, Rosenberg WM. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology 2009;136:160-167.","DOI":"10.1053\/j.gastro.2008.09.013"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Ceppa P, Testa R. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 2003;163:218-224.","DOI":"10.1001\/archinte.163.2.218"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Lackner C, Struber G, Liegl B, Leibl S, Ofner P, Bankuti C, Bauer B, Stauber RE. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C. Hepatology 2005;41:1376-1382.","DOI":"10.1002\/hep.20717"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2007;13:525-531.","DOI":"10.3748\/wjg.v13.i4.525"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, Lok AS. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003;38:518-526.","DOI":"10.1053\/jhep.2003.50346"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Sebastiani G, Vario A, Guido M, Noventa F, Plebani M, Pistis R, Ferrari A, Alberti A. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol 2006;44:686-693.","DOI":"10.1016\/j.jhep.2006.01.007"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Lok AS, Ghany MG, Goodman ZD, Wright EC, Everson GT, Sterling RK, Everhart JE, Lindsay KL, Bonkovsky HL, Di Bisceglie AM. Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology 2005;42:282-292.","DOI":"10.1002\/hep.20772"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Forns X, Ampurdanes S, Llovet JM, Aponte J, Quinto L, Martinez-Bauer E, Bruguera M, Sanchez-Tapias JM, Rodes J. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2002;36:986-992.","DOI":"10.1053\/jhep.2002.36128"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Thabut D, Simon M, Myers RP, Messous D, Thibault V, Imbert-Bismut F, Poynard T. Noninvasive prediction of fibrosis in patients with chronic hepatitis C. Hepatology 2003;37:1220-1221; author reply 1221.","DOI":"10.1053\/jhep.2003.50109"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology 2007;45:297-306.","DOI":"10.1002\/hep.21520"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Sebastiani G, Vario A, Guido M, Alberti A. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases. J Viral Hepat 2008;15:212-218.","DOI":"10.1111\/j.1365-2893.2007.00932.x"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology 2007;46:32-36.","DOI":"10.1002\/hep.21669"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Mallet V, Dhalluin-Venier V, Roussin C, Bourliere M, Pettinelli ME, Giry C, Vallet-Pichard A, Fontaine H, Pol S. The accuracy of the FIB-4 index for the diagnosis of mild fibrosis in chronic hepatitis B. Aliment Pharmacol Ther 2009;29:409-415.","DOI":"10.1111\/j.1365-2036.2008.03895.x"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Loko MA, Castera L, Dabis F, Le Bail B, Winnock M, Coureau G, Bioulac-Sage P, de Ledinghen V, Neau D. Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort. Am J Gastroenterol 2008;103:1973-1980.","DOI":"10.1111\/j.1572-0241.2008.01954.x"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-1075.","DOI":"10.1016\/S0140-6736(00)04258-6"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Myers RP, Tainturier MH, Ratziu V, Piton A, Thibault V, Imbert-Bismut F, Messous D, Charlotte F, Di Martino V, Benhamou Y. Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B. J Hepatol 2003;39:222-230.","DOI":"10.1016\/S0168-8278(03)00171-5"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Myers RP, Benhamou Y, Imbert-Bismut F, Thibault V, Bochet M, Charlotte F, Ratziu V, Bricaire F, Katlama C, Poynard T. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients. AIDS 2003;17:721-725.","DOI":"10.1097\/00002030-200303280-00010"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Naveau S, Raynard B, Ratziu V, Abella A, Imbert-Bismut F, Messous D, Beuzen F, Capron F, Thabut D, Munteanu M. Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease. Clin Gastroenterol Hepatol 2005;3:167-174.","DOI":"10.1016\/S1542-3565(04)00625-1"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Ratziu V, Massard J, Charlotte F, Messous D, Imbert-Bismut F, Bonyhay L, Tahiri M, Munteanu M, Thabut D, Cadranel JF. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. BMC Gastroenterol 2006;6:6.","DOI":"10.1186\/1471-230X-6-6"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, Christidis C, Ziol M, Poulet B, Kazemi F. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-1713.","DOI":"10.1016\/j.ultrasmedbio.2003.07.001"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Colombo M. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007;56:968-973.","DOI":"10.1136\/gut.2006.111302"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Ledinghen V. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-350.","DOI":"10.1053\/j.gastro.2004.11.018"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Ledinghen V, Marcellin P, Dhumeaux D, Trinchet JC. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005;41:48-54.","DOI":"10.1002\/hep.20506"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008;48:835-847.","DOI":"10.1016\/j.jhep.2008.02.008"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Foucher J, Chanteloup E, Vergniol J, Castera L, Le Bail B, Adhoute X, Bertet J, Couzigou P, de Ledinghen V. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006;55:403-408.","DOI":"10.1136\/gut.2005.069153"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Ganne-Carrie N, Ziol M, de Ledinghen V, Douvin C, Marcellin P, Castera L, Dhumeaux D, Trinchet JC, Beaugrand M. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases. Hepatology 2006;44:1511-1517.","DOI":"10.1002\/hep.21420"},{"key":"ref88","doi-asserted-by":"crossref","unstructured":"Coco B, Oliveri F, Maina AM, Ciccorossi P, Sacco R, Colombatto P, Bonino F, Brunetto MR. Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 2007;14:360-369.","DOI":"10.1111\/j.1365-2893.2006.00811.x"},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Oliveri F, Coco B, Ciccorossi P, Colombatto P, Romagnoli V, Cherubini B, Bonino F, Brunetto MR. Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases. World J Gastroenterol 2008;14:6154-6162.","DOI":"10.3748\/wjg.14.6154"},{"key":"ref90","doi-asserted-by":"crossref","unstructured":"Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, Moscarella S, Boddi V, Petrarca A, Laffi G. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008;47:380-384.","DOI":"10.1002\/hep.22007"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Nguyen-Khac E, Chatelain D, Tramier B, Decrombecque C, Robert B, Joly JP, Brevet M, Grignon P, Lion S, Le Page L. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests. Aliment Pharmacol Ther 2008;28:1188-1198.","DOI":"10.1111\/j.1365-2036.2008.03831.x"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, Herrmann E. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008;134:960-974.","DOI":"10.1053\/j.gastro.2008.01.034"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Alberti A, Clumeck N, Collins S, Gerlich W, Lundgren J, Palu G, Reiss P, Thiebaut R, Weiland O, Yazdanpanah Y. Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol 2005;42:615-624.","DOI":"10.1016\/j.jhep.2005.03.003"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Sebastiani G, Halfon P, Castera L, Pol S, Thomas DL, Mangia A, Marco VD, Pirisi M, Voiculescu M, Guido M. SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology 2009;42:Epub ahead of print.","DOI":"10.1002\/hep.22859"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Sebastiani G, Halfon P, Castera L, Mangia A, Di Marco V, Pirisi M, Voiculescu M, Bourliere M, Alberti A. Large-scale multicenter comparison of three algorithms combining serum non-invasive markers for liver fibrosis in chronic hepatitis C. J Hepatol 2008;48:S282.","DOI":"10.1016\/S0168-8278(08)60758-8"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Bourliere M, Penaranda G, Renou C, Botta-Fridlund D, Tran A, Portal I, Lecomte L, Castellani P, Rosenthal-Allieri MA, Gerolami R. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies. J Viral Hepat 2006;13:659-670.","DOI":"10.1111\/j.1365-2893.2006.00736.x"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"Leroy V, Hilleret MN, Sturm N, Trocme C, Renversez JC, Faure P, Morel F, Zarski JP. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol 2007;46:775-782.","DOI":"10.1016\/j.jhep.2006.12.013"},{"key":"ref98","unstructured":"Castera L, Sebastiani G, Le Bail B, de Ledinghen V, Couzigou P, Alberti A. Prospective comparison of two algorithms combining non-invasive methods for liver fibrosis in chronic hepatitis C. Hepatology 2007;46:A186."},{"key":"ref99","doi-asserted-by":"crossref","unstructured":"Pinzani M, Vizzutti F, Arena U, Marra F. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Nat Clin Pract Gastroenterol Hepatol 2008;5:95-106.","DOI":"10.1038\/ncpgasthep1025"},{"key":"ref100","doi-asserted-by":"crossref","unstructured":"d’Arondel C, Munteanu M, Moussalli J, Thibault V, Naveau S, Simon A, Messous D, Morra R, Blot C, Poynard T. A prospective assessment of an ‘a la carte’ regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers. J Viral Hepat 2006;13:182-189.","DOI":"10.1111\/j.1365-2893.2005.00668.x"},{"key":"ref101","doi-asserted-by":"crossref","unstructured":"Hezode C, Mallat A, Castera L, Rosa I, Roulot D, Leroy V, Bouvier-Alias M, Pawlotsky J, Roudot-Thoraval F. Prospective evaluation of liver stiffness dynamics during and after peginterferon alpha-ribavirin treatment in patients with chronic hepatitis C. Hepatology 2008;48:A1215.","DOI":"10.1016\/S0168-8278(08)60795-3"},{"key":"ref102","unstructured":"Lim S, Cheong J, Cho S. Changes in liver stiffness during entecavir therapy in patients with chronic hepatitis B. Hepatology 2008;48:A938."},{"key":"ref103","doi-asserted-by":"crossref","unstructured":"Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, Petrarca A, Moscarella S, Belli G, Zignego AL. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology 2007;45:1290-1297.","DOI":"10.1002\/hep.21665"},{"key":"ref104","doi-asserted-by":"crossref","unstructured":"Sanyal AJ, Fontana RJ, Di Bisceglie AM, Everhart JE, Doherty MC, Everson GT, Donovan , Donovan JA, Malet PF, Mehta S, Sheikh MY. The prevalence and risk factors associated with esophageal varices in subjects with hepatitis C and advanced fibrosis. Gastrointest Endosc 2006;64:855-864.","DOI":"10.1016\/j.gie.2006.03.007"},{"key":"ref105","doi-asserted-by":"crossref","unstructured":"Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E, Sohaey R, Verhey P, Peck-Radosavljevic M, Mansi C. Platelet count\/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. Am J Gastroenterol 2006;101:2511-2519.","DOI":"10.1111\/j.1572-0241.2006.00874.x"},{"key":"ref106","doi-asserted-by":"crossref","unstructured":"Sebastiani G, Alberti A, Castera L, Halfon P, Bourliere M, Angeli P, Mazza E, Maggioro A, Tempesta D. Prediction of oesophageal varices (OV) in hepatic cirrhosis by simple non invasive markers: results of a multicenter, International study. Hepatology 2008;48:A713.","DOI":"10.1016\/S1590-8658(09)60061-X"},{"key":"ref107","doi-asserted-by":"crossref","unstructured":"Castera L, Le Bail B, Roudot-Thoraval F, Bernard PH, Foucher J, Merrouche W, Couzigou P, de Ledinghen V. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol 2009;50:59-68.","DOI":"10.1016\/j.jhep.2008.08.018"},{"key":"ref108","doi-asserted-by":"crossref","unstructured":"Carrion JA, Navasa M, Bosch J, Bruguera M, Gilabert R, Forns X. Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation. Liver Transpl 2006;12:1791-1798.","DOI":"10.1002\/lt.20857"},{"key":"ref109","doi-asserted-by":"crossref","unstructured":"Bureau C, Metivier S, Peron JM, Robic MA, Rouquet O, Dupuis E, Vinel T. Prospective assessment of liver stiffness for the non-invasive prediction of portal hypertension. J Hepatol 2007;46 (Suppl 1):S34.","DOI":"10.1016\/S0168-8278(07)61675-4"},{"key":"ref110","unstructured":"Lemoine M, Katsahian S, Nahon P, Ganne-Carrie N, Kazemi F, Grando V. Liver stiffness measurement is correlated with hepatic venous pressure gradient in patients with uncomplicated alcoholic and\/or HCV related cirrhosis. Hepatology 2006;44 (Suppl 1):A204."},{"key":"ref111","unstructured":"Rudler M, Massard J, Varaut A, Lebray P, Poynard T, Thabut D, Cluzel P, Auguste M. Transient Elastography (Fibroscan) and Hepatic Venous Pressure Gradient Measurement in Patients with Cirrhosis and Gastrointestinal Haemorrhage related to Portal Hypertension. Hepatology 2008;48 (Suppl 1):A36."},{"key":"ref112","unstructured":"Bradford Y, Gerotto M, Marcolongo M, Dal Pero F, Lagier R, Rowland C, Sebastiani G, Alberti A. A cirrhosis risk score identifies those chronic hepatitis C infected patients presenting with no liver fibrosis that are at high risk for fibrosis progression. Hepatology 2007;46 (Suppl 1):A459."}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i18\/2190.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T04:28:48Z","timestamp":1589776128000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i18\/2190.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":112,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.2190","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}